相关实验视频

Updated: Jun 4, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

BDNF rs6265与多发性硬化症之间缺乏关联:一个病例对照研究

Ioannis Liampas^1,2, Daniil Tsirelis^1,2, Metaxia Dastamani^1,2

¹Department of Neurology, School of Medicine, University Hospital of Larissa, University of Thessaly, 41110, Larissa, Greece.

Journal of molecular neuroscience : MN

|December 17, 2024

概括

这项研究发现BDNF rs6265基因变异与多发性硬化症 (MS) 风险,发病年龄或疾病特征之间没有联系. 需要进一步的研究来澄清遗传因素在MS中的作用.

科学领域:

神经遗传学神经遗传学
免疫学免疫学免疫学
人类遗传学人类遗传学

背景情况:

多发性硬化症 (MS) 的遗传基础是复杂的,并未完全理解.
大脑衍生神经营养因子 (BDNF) 基因变异,特别是rs6265,已被研究出它们在各种神经疾病中的潜在作用.
目前关于BDNF rs6265和MS之间关联的数据有限,并呈现相互矛盾的结果.

研究的目的:

调查BDNFrs6265多态性和患多发性硬化症的风险之间的关联.
探索BDNF rs6265与二次结果之间的关系,包括MS发病年龄,脊椎病变的存在和发病时的临床表现.

主要方法:

研究人员对200名新诊断的多发性硬化患者和205名健康对照进行了病例控制研究.
进行了BDNF rs6265多态的基因定型.
统计分析包括后勤回归和Cox比例模型,以评估与MS风险和临床参数的关联.

主要成果:

在各种遗传模型中,BDNF rs6265多态和多发性硬化症风险之间没有发现统计学上显著的关联.
在未调整或性别调整的分析中,rs6265多态性与MS发病年龄没有显著的关系.
没有观察到rs6265与脊椎病变或MS发病时的特定临床表现存在的相关性.

结论:

BDNF rs6265多态性似乎与多发性硬化症的风险无关.
这种遗传变异与MS患者的发病年龄,脊髓损伤存在或初始临床表现无关.
需要进一步研究其他影响MS易感性和进展的遗传因素.

关键词:

这就是为什么BDNF是BDNF.多发性硬化症是多发性硬化症.需要 rs6265 的钱.

更多相关视频

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...